Diagnosing diabetes and heart disease series of medical device products

After six years of hard research and development, the company finally achieved great results. On May 20, the reporter learned at the press conference held by Changzhou Delphi Technology Co., Ltd. that the company developed diabetes and heart disease jointly with universities such as Nanjing University and Huazhong University of Science and Technology. A series of medical devices will be put on the market soon.

Changzhou Delphi Technology Co., Ltd. is invested by Jiangsu Huayang Electric Co., Ltd., which is a high-tech enterprise integrating research, development, production, sales and service of medical devices. It focuses on providing safe and reliable health care equipment for patients with diabetes and heart disease. OEM/ODM, a pharmaceutical manufacturer and operator, provides innovative and win-win product technology solutions and is the most professional and comprehensive syringe manufacturer in China.

Six years ago, Huayang Electric and Nanjing University signed a contract for diabetes treatment projects, which created a road of cooperation between Huayang and colleges. At present, Delphi can provide more than ten products in three series of diabetes medical devices, mainly mechanical, electronic automatic, electronic hidden needle, and intelligent electronic injectors. Among them, the syringe series has obtained the registration certificate and went on sale, and the blood glucose real-time monitor and insulin pump are currently in the clinical stage. The well-known domestic pharmaceutical manufacturers Changchun Jinsai, Changchun Baiyi, Gansu Chengji Pharmaceutical, etc. all started negotiations and signed with the company. In the project research and development, internationally renowned pharmaceutical giants also donated olive branches from time to time. Customers from India, Pakistan and Turkey made a special trip to the Delphi factory to investigate and cooperate with the agents. At the Shanghai International Pharmaceutical Machinery Exhibition, which just ended on May 17, Delphi's diabetes series injection equipment and heart rate instrument products received special attention from visitors. Egyptian customers signed 10,000 injection equipment trial orders on the spot.

The reporter saw at the scene that the diabetes series injection device is slightly larger than the pen and has high precision. It can be used for different groups from newborn babies to the elderly. It is very convenient to use. The heart rate real-time monitor placed on the stand is the third generation product developed by the company. There are two types of electrocardiographs with portable home type and remote object control technology. They look more like a small player, which is easy to use in a portable way. With two fingers on two electrodes, you can instantly get the heart beat. This product belongs to the category of mobile medicine, allowing patients to detect heart rhythm at any time at home.

Zou Jiangang, director of the Department of Cardiology of the Provincial People's Hospital, said that after two years of clinical trials of 67 groups of patients, the quality of the heart rate monitoring analyzer developed by Delphi has met the national standards, the validity and accuracy of the diagnosis of various arrhythmia and the electrocardiogram used in hospitals. There was no difference in the machine, and no obvious adverse events and side effects occurred.

At present, the world has gradually entered the era of universal health care industry. Mobile medical care, smart medical care, and big data medical care have entered every family. The medical industry has an urgent need for the application of remote IoT technology. The company plans to open up the national market distribution channel in one year, and achieve sales of 200 million yuan in three years, and will be listed on the third board or the GEM.